Clinical and in vitro studies have demonstrated that retinoic acid could induce redifferentiation of thyroid cancer cells, increase the expression of NIS and uptake of radioactive iodine, and therefore increase the efficacy of radioiodine therapy [139, 140]. Here, SLC5A5 is linked to thyroid gland carcinoma.